Video Modules

Share

Program Content

Activities

  • Frontline HNSCC Immunotherapy
    Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 10, 2020

    Expires: November 09, 2021

  • Treating Head and Neck Cancer
    The Current Treatment Landscape in Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 11, 2020

    Expires: November 10, 2021

  • Future HNSCC Immunotherapy
    Exploring Future Roles for Immune-Oncology in Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2020

    Expires: December 17, 2021

  • NTRK Fusions in H&N
    Rationale for Targeting NTRK Fusions in Head and Neck Cancers
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 21, 2020

    Expires: December 20, 2021

  • Testing for <em>NTRK</em> Fusions
    NTRK Fusions: Who To Test? When To Test?
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 21, 2020

    Expires: December 20, 2021

  • NTRK Inhibitor Management
    Management Options for NTRK Fusion-positive Patients With Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 22, 2020

    Expires: December 21, 2021

  • irAEs in Head and Neck Cancer
    Strategies for Managing Immune-Related Adverse Events in Patients With Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 08, 2021

    Expires: March 07, 2022

  • Head, Neck Cancer Testing
    The Importance of Molecular Testing in Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 18, 2021

    Expires: March 17, 2022

  • Immune Escape in HNSCC
    The Role of the Immune System and Immune Escape in Head and Neck Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 22, 2021

    Expires: March 21, 2022

  • IO Biomarkers in HNSCC
    Predictive Biomarkers for Immunotherapy in HNSCC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 22, 2021

    Expires: March 21, 2022

Faculty

cover img faculity

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut

cover img faculity

Barbara Burtness, MD

Anthony N. Brady Professor of Medicine
Yale School of Medicine
Chief Translational Research Officer
Division Chief
Head and Neck/Sarcoma Oncology
Co-leader
Developmental Therapeutics Program
Director
Yale Head and Neck SPORE
Yale Cancer Center
Chair
ECOG-ACRIN Cancer Research Group
New Haven, Connecticut

cover img faculity

Elisabeth King, RN, FNP, AGN, AOCNP

Executive Director of Genomics and Precision Medicine
City of Hope
Duarte, California

cover img faculity

Daniel Zalinov, PA-C

Internal Medicine
Atrium Health
Charlotte, North Carolina

cover img faculity

Dan P. Zandberg, MD

Associate Professor of Medicine and Otolaryngology
Director
, Head and Neck and Thyroid Cancer Disease Sections
Division of Hematology/Oncology
Medical Oncology Co-Leader, Head and Neck Program
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.